Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice
- PMID: 32244295
- PMCID: PMC7177925
- DOI: 10.3390/ijms21072395
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons (MN). Importantly, MN degeneration is intimately linked to oligodendrocyte dysfunction and impaired capacity of oligodendrocyte precursor cells (OPCs) to regenerate the myelin sheath enwrapping and protecting neuronal axons. Thus, improving OPC reparative abilities represents an innovative approach to counteract MN loss. A pivotal regulator of OPC maturation is the P2Y-like G protein-coupled receptor 17 (GPR17), whose role in ALS has never been investigated. In other models of neurodegeneration, an abnormal increase of GPR17 has been invariably associated to myelin defects and its pharmacological manipulation succeeded in restoring endogenous remyelination. Here, we analyzed GPR17 alterations in the SOD1G93A ALS mouse model and assessed in vitro whether this receptor could be targeted to correct oligodendrocyte alterations. Western-blot and immunohistochemical analyses showed that GPR17 protein levels are significantly increased in spinal cord of ALS mice at pre-symptomatic stage; this alteration is exacerbated at late symptomatic phases. Concomitantly, mature oligodendrocytes degenerate and are not successfully replaced. Moreover, OPCs isolated from spinal cord of SOD1G93A mice display defective differentiation compared to control cells, which is rescued by treatment with the GPR17 antagonist montelukast. These data open novel therapeutic perspectives for ALS management.
Keywords: G protein-coupled receptor 17 (GPR17); SOD1G93A ALS mouse model; amyotrophic lateral sclerosis (ALS); montelukast; oligodendrocytes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity.Br J Pharmacol. 2024 Sep;181(18):3303-3326. doi: 10.1111/bph.16408. Epub 2024 May 15. Br J Pharmacol. 2024. PMID: 38751168
-
The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.Int J Biol Sci. 2016 Aug 15;12(9):1140-9. doi: 10.7150/ijbs.15938. eCollection 2016. Int J Biol Sci. 2016. PMID: 27570488 Free PMC article.
-
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.Neuropharmacology. 2016 May;104:82-93. doi: 10.1016/j.neuropharm.2015.10.005. Epub 2015 Oct 8. Neuropharmacology. 2016. PMID: 26453964 Review.
-
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.Glia. 2018 May;66(5):1118-1130. doi: 10.1002/glia.23305. Epub 2018 Feb 9. Glia. 2018. PMID: 29424466 Free PMC article.
-
Regulation and signaling of the GPR17 receptor in oligodendroglial cells.Glia. 2020 Oct;68(10):1957-1967. doi: 10.1002/glia.23807. Epub 2020 Feb 22. Glia. 2020. PMID: 32086854 Review.
Cited by
-
A Glance at the Molecules That Regulate Oligodendrocyte Myelination.Curr Issues Mol Biol. 2022 May 15;44(5):2194-2216. doi: 10.3390/cimb44050149. Curr Issues Mol Biol. 2022. PMID: 35678678 Free PMC article. Review.
-
Ethanol effects on cerebellar myelination in a postnatal mouse model of fetal alcohol spectrum disorders.Alcohol. 2021 Nov;96:43-53. doi: 10.1016/j.alcohol.2021.07.003. Epub 2021 Aug 4. Alcohol. 2021. PMID: 34358666 Free PMC article.
-
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2023 Mar 9;24(6):5240. doi: 10.3390/ijms24065240. Int J Mol Sci. 2023. PMID: 36982315 Free PMC article. Review.
-
Elucidating the Molecular Mechanism of Ischemic Stroke Using Integrated Analysis of miRNA, mRNA, and lncRNA Expression Profiles.Front Integr Neurosci. 2021 Aug 16;15:638114. doi: 10.3389/fnint.2021.638114. eCollection 2021. Front Integr Neurosci. 2021. PMID: 34483854 Free PMC article.
-
Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2021 Mar 26;22(7):3426. doi: 10.3390/ijms22073426. Int J Mol Sci. 2021. PMID: 33810425 Free PMC article. Review.
References
-
- Rafałowska J., Dziewulska D. White matter injury in amyotrophic lateral sclerosis (ALS) Folia Neuropathol. 1996;34:87–91. - PubMed
-
- Mollink J., Hiemstra M., Miller K.L., Huszar I.N., Jenkinson M., Raaphorst J., Wiesmann M., Ansorge O., Pallebage-Gamarallage M., van Cappellen van Walsum A.M. White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2019;45:570–585. doi: 10.1111/nan.12555. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous